Spots Global Cancer Trial Database for advanced biliary tract cancer
Every month we try and update this database with for advanced biliary tract cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer | NCT03796429 | Biliary Tract C... | GS+Toripalimab | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN) | NCT05410197 | Advanced Biliar... | Envofolimab Lenvatinib Gemcitabine Cisplatin | 18 Years - | Sun Yat-sen University | |
| Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer | NCT03358849 | Advanced Biliar... | Natural killer ... | 18 Years - 75 Years | Yonsei University | |
| Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer | NCT05820906 | Advanced Biliar... | Cadonilimab+Reg... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507 | NCT02597465 | Advanced Biliar... | SPARC1507 Reference1507 | 18 Years - | Sun Pharma Advanced Research Company Limited | |
| NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer | NCT04005339 | Advanced Biliar... | Nanoliposomal I... Leucovorin Fluorouracil | 18 Years - | Georgetown University | |
| Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment | NCT05170438 | Advanced Biliar... | Lenvatinib Pill... | 20 Years - | National Health Research Institutes, Taiwan | |
| Phase II Study of Sitravatinib in Combination With Tislelizumab in Patients With Advanced Biliary Tract Cancer | NCT04727996 | Advanced Biliar... | Sitravatinib Tislelizumab | 19 Years - | Seoul National University Hospital | |
| Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer | NCT05009953 | Advanced Biliar... Intrahepatic Ch... Extrahepatic Ch... Gallbladder Car... | Irinotecan Lipo... SG001 Fluorouracil Leucovorin | 18 Years - | CSPC Ouyi Pharmaceutical Co., Ltd. | |
| Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08） | NCT05781074 | Advanced Biliar... | Sintilimab Lenvatinib Cryoablation | 18 Years - | Fudan University | |
| Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers | NCT04211168 | Advanced Biliar... | Toripalimab plu... | 18 Years - | Peking Union Medical College Hospital | |
| NGS as the First-line Treatment in Advanced Biliary Tract Cancer | NCT04172402 | Advanced Biliar... | TS-1 Gemcitabine Nivolumab | 20 Years - | National Health Research Institutes, Taiwan | |
| A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer | NCT03796429 | Biliary Tract C... | GS+Toripalimab | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer | NCT03796429 | Biliary Tract C... | GS+Toripalimab | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer | NCT05820906 | Advanced Biliar... | Cadonilimab+Reg... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Combination Immunotherapy in Rare Cancers Under InvesTigation | NCT04969887 | Advanced Biliar... Neuroendocrine ... Female Reproduc... MSI-H Solid Mal... | Ipilimumab Nivolumab | 18 Years - | Olivia Newton-John Cancer Research Institute | |
| HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC | NCT04217954 | Advanced Biliar... | OXA, 5-FU and b... | 18 Years - 80 Years | Peking University | |
| Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer | NCT05812430 | Advanced Biliar... | anlotinib+TQB24... | 18 Years - 75 Years | The First Affiliated Hospital of Zhengzhou University | |
| Phase II Study of Sitravatinib in Combination With Tislelizumab in Patients With Advanced Biliary Tract Cancer | NCT04727996 | Advanced Biliar... | Sitravatinib Tislelizumab | 19 Years - | Seoul National University Hospital | |
| Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer | NCT03358849 | Advanced Biliar... | Natural killer ... | 18 Years - 75 Years | Yonsei University | |
| A Phase 1/2 Study of SC-43 in Combination With Cisplatin | NCT04733521 | Advanced Non-sm... Advanced Biliar... | SC-43 Cisplatin | 18 Years - | RaND Biosciences | |
| Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment | NCT05170438 | Advanced Biliar... | Lenvatinib Pill... | 20 Years - | National Health Research Institutes, Taiwan | |
| Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08） | NCT05781074 | Advanced Biliar... | Sintilimab Lenvatinib Cryoablation | 18 Years - | Fudan University | |
| The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers | NCT04781192 | Advanced Biliar... | Durvalumab Regorafenib | 18 Years - | University of Kansas Medical Center | |
| IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer | NCT05653180 | Advanced Biliar... | IBI310 sintilimab | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. | |
| Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment | NCT05170438 | Advanced Biliar... | Lenvatinib Pill... | 20 Years - | National Health Research Institutes, Taiwan | |
| Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers | NCT02829918 | Biliary Tract C... Biliary Tract N... | Nivolumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
